199 related articles for article (PubMed ID: 9626160)
1. Fas/Fas ligand up-regulation and Bcl-2 down-regulation may be significant in the pathogenesis of Hashimoto's thyroiditis.
Mitsiades N; Poulaki V; Kotoula V; Mastorakos G; Tseleni-Balafouta S; Koutras DA; Tsokos M
J Clin Endocrinol Metab; 1998 Jun; 83(6):2199-203. PubMed ID: 9626160
[TBL] [Abstract][Full Text] [Related]
2. [Expression of apoptosis-related proteins in Hashimoto's thyroiditis and its pathological significance].
Zhang Y; Ji Q; Zhang W
Zhonghua Yi Xue Za Zhi; 2001 Apr; 81(7):432-4. PubMed ID: 11798914
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the expression of Fas, FasL and Bcl-2 in the pathogenesis of autoimmune thyroid disorders.
Chen S; Fazle Akbar SM; Zhen Z; Luo Y; Deng L; Huang H; Chen L; Li W
Cell Mol Immunol; 2004 Jun; 1(3):224-8. PubMed ID: 16219172
[TBL] [Abstract][Full Text] [Related]
4. Expression and distribution of S-100 protein, CD83 and apoptosis-related proteins (Fas, FasL and Bcl-2) in thyroid tissues of autoimmune thyroid diseases.
Xu WC; Chen SR; Huang JX; Zheng ZC; Chen LX; Lin JJ; Li YG
Eur J Histochem; 2007; 51(4):291-300. PubMed ID: 18162459
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of Fas-mediated apoptosis in both thyrocyte and lymphocyte cellular compartments correlates with opposite phenotypic manifestations of autoimmune thyroid disease.
Giordano C; Richiusa P; Bagnasco M; Pizzolanti G; Di Blasi F; Sbriglia MS; Mattina A; Pesce G; Montagna P; Capone F; Misiano G; Scorsone A; Pugliese A; Galluzzo A
Thyroid; 2001 Mar; 11(3):233-44. PubMed ID: 11327614
[TBL] [Abstract][Full Text] [Related]
6. [Apoptosis in Hashimoto's thyroiditis].
Kotani T; Aratake Y; Ohtaki S
Rinsho Byori; 1997 Nov; 45(11):1038-47. PubMed ID: 9396343
[TBL] [Abstract][Full Text] [Related]
7. Regulation of apoptosis in endocrine autoimmunity: insights from Hashimoto's thyroiditis and Graves' disease.
Salmaso C; Bagnasco M; Pesce G; Montagna P; Brizzolara R; Altrinetti V; Richiusa P; Galluzzo A; Giordano C
Ann N Y Acad Sci; 2002 Jun; 966():496-501. PubMed ID: 12114310
[TBL] [Abstract][Full Text] [Related]
8. Identification of apoptotic proteins in thyroid gland from patients with Graves' disease and Hashimoto's thyroiditis.
Bossowski A; Czarnocka B; Bardadin K; Stasiak-Barmuta A; Urban M; Dadan J; Ratomski K; Bossowska A
Autoimmunity; 2008 Mar; 41(2):163-73. PubMed ID: 18324486
[TBL] [Abstract][Full Text] [Related]
9. Analysis of apoptosis in relation to tissue destruction associated with Hashimoto's autoimmune thyroiditis.
Hammond LJ; Lowdell MW; Cerrano PG; Goode AW; Bottazzo GF; Mirakian R
J Pathol; 1997 Jun; 182(2):138-44. PubMed ID: 9274522
[TBL] [Abstract][Full Text] [Related]
10. Fas/Fas ligand-driven T cell apoptosis as a consequence of ineffective thyroid immunoprivilege in Hashimoto's thyroiditis.
Stassi G; Todaro M; Bucchieri F; Stoppacciaro A; Farina F; Zummo G; Testi R; De Maria R
J Immunol; 1999 Jan; 162(1):263-7. PubMed ID: 9886394
[TBL] [Abstract][Full Text] [Related]
11. [The role of apoptosis in the etiopathogenesis of autoimmune thyroiditis].
Łacka K; Maciejewski A
Pol Merkur Lekarski; 2012 Feb; 32(188):87-92. PubMed ID: 22590910
[TBL] [Abstract][Full Text] [Related]
12. Is lymphocytic thyroiditis a unique type or merely a type of Hashimoto's thyroiditis?
Todorovic J; Nesovic Ostojic J; Opric D; Dundjerovic D; Bozic V; Markovic L
Minerva Med; 2014 Aug; 105(4):303-12. PubMed ID: 24867187
[TBL] [Abstract][Full Text] [Related]
13. Soluble Fas, Fas ligand and Bcl-2 in autoimmune thyroid diseases: relation to humoral immune response markers.
Myśliwiec J; Okota M; Nikołajuk A; Górska M
Adv Med Sci; 2006; 51():119-22. PubMed ID: 17357290
[TBL] [Abstract][Full Text] [Related]
14. The role of apoptosis in thyroid disease.
Tsatsoulis A
Minerva Med; 2002 Jun; 93(3):169-80. PubMed ID: 12094148
[TBL] [Abstract][Full Text] [Related]
15. [Cytofluorometric analysis of chosen markers of apoptosis CD95/CD95L (Fas/FasL) in thyroid tissues from young patients with Graves' disease and Hashimoto's thyroiditis].
Bossowski A; Stasiak-Barmuta A; Czarnocka B; Urban M; Łyczkowska A; Niedziela M; Bardadin K; Czerwińska J; Dadan J; Baltaziak M
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(2):83-90. PubMed ID: 16813711
[TBL] [Abstract][Full Text] [Related]
16. Thyrocyte targets and effectors of autoimmunity: a role for death receptors?
Hammond LJ; Palazzo FF; Shattock M; Goode AW; Mirakian R
Thyroid; 2001 Oct; 11(10):919-27. PubMed ID: 11716038
[TBL] [Abstract][Full Text] [Related]
17. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis.
Giordano C; Stassi G; De Maria R; Todaro M; Richiusa P; Papoff G; Ruberti G; Bagnasco M; Testi R; Galluzzo A
Science; 1997 Feb; 275(5302):960-3. PubMed ID: 9020075
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of Fas, FasL and Caspase-8 expression in thyroid gland in young patients with immune and non-immune thyroid diseases].
Bossowski A; Czarnocka B; Stasiak-Barmuta A; Bardadin K; Urban M; Dadan J
Endokrynol Pol; 2007; 58(4):303-13. PubMed ID: 18058722
[TBL] [Abstract][Full Text] [Related]
19. ECP-treated lymphocytes of chronic graft-versus-host disease patients undergo apoptosis which involves both the Fas/FasL system and the Bcl-2 protein family.
Di Renzo M; Rubegni P; Sbano P; Cuccia A; Castagnini C; Pompella G; Pasqui AL; Capecchi PL; Auteri A; Laghi Pasini F; Fimiani M
Arch Dermatol Res; 2003 Sep; 295(5):175-82. PubMed ID: 12883827
[TBL] [Abstract][Full Text] [Related]
20. Functional Fas ligand expression in thyrocytes from patients with Graves' disease.
Hiromatsu Y; Hoshino T; Yagita H; Koga M; Sakisaka S; Honda J; Yang D; Kayagaki N; Okumura K; Nonaka K
J Clin Endocrinol Metab; 1999 Aug; 84(8):2896-902. PubMed ID: 10443697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
